Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04689854 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cervical Interbody Implant Study

StatusEnrolling by Invitation
PhaseNot specified
SponsorNuVasive
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 22, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025v12
  2. Minor Re-verified, no change to tracked fieldsv11
  3. Minor Study sites: 6 to 7v10
  4. Minor Re-verified, no change to tracked fieldsv9
  5. Minor Study sites: 5 to 6v8
Show 6 earlier versionsHide 6 earlier versions
  1. Minor Study sites: 4 to 5
    • Secondary endpoints: 4 to 7
    • Eligibility criteria shortened, about 2 words
    v7
  2. Minor 2 versions Re-verified since Feb 16, 2022, no change to tracked fieldsv5-v6
  3. Minor Study sites: 3 to 4v4
  4. Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 3
    • Start date changed from estimate of Feb 28, 2021 to Jul 7, 2020
    v3
  5. Notable Start date: Dec 31, 2020 to Feb 28, 2021
    • Secondary endpoints revised (4)
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
13 trials monitored
See all monitored trials
The primary objective of this study is to evaluate the safety and performance of cervical spine surgery using interbody implants as measured by reported complications, radiographic outcomes, and patient-reported outcomes (PROs).
Trial Details
NCT Number NCT04689854
Lead Sponsor NuVasive
Conditions
(from sponsor)
Degenerative Disc Disease, Cervical Spinal Instability
Related terms Intervertebral Disc Degeneration
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov